Status:

COMPLETED

Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients

Lead Sponsor:

Boehringer Ingelheim

Conditions:

HIV Infections

Quality of Life

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this trial is to compare the effect of switching to nevirapine (Viramune®)-containing regimen on quality of life of patients with fat abnormalities and virological control whilst receiv...

Detailed Description

Patients will receive one of the current standard of care regimens for the treatment of HIV infection, i.e. nevirapine (Viramune®) must be administered in conjunction with 2NRTIs, as prescribed by the...

Eligibility Criteria

Inclusion

  • Main Inclusion criteria:
  • Subject suffering with clinically evident fat redistribution including the lipodystrophic syndrome and/or with abnormal values of triglycerides, cholesterol and/or insulin resistance
  • Subject on treatment with HAART including PIs for at least 9 months, without therapeutic changes for at least 6 months
  • Baseline CD4+ \>200 cells/mm3
  • HIV-1 RNA levels \<200 copies/mL at baseline and during the previous 6 months
  • Main Exclusion criteria:
  • Subject with other serious or chronic disease unrelated to HIV
  • Subject with active invasive infections
  • Subject with Karnofsky score less than 50
  • Prior NNRTs experience
  • Documented or suspected acute hepatitis within 30 days prior to baseline visit, irrespective of AST and ALT values that are \>5 ULN
  • Subject receiving hypolipidemic and/or antidiabetic drugs at study entry
  • Subjects with central nervous system disease or pre-existing mental disturbance
  • Subjects on methadone chronic treatment at study entry

Exclusion

    Key Trial Info

    Start Date :

    September 1 2001

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 1 2004

    Estimated Enrollment :

    158 Patients enrolled

    Trial Details

    Trial ID

    NCT00274001

    Start Date

    September 1 2001

    End Date

    March 1 2004

    Last Update

    November 1 2013

    Active Locations (24)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 6 (24 locations)

    1

    Ospedale Regionale

    Ancona, Italy, 60020

    2

    Ospedale Santa Maria Annunziata

    Antella (fi), Italy, 50011

    3

    Clinica di Malattie Infettive

    Bari, Italy, 70124

    4

    Ospedali Riuniti di Bergamo

    Bergamo, Italy, 24128